Yibao Ma worked with a team of researchers from Wuhan University, China, to study the sting of S. jendeki, a member of the family Euscorpiidae, which covers Europe, Asia, Africa, and America.
He said, "Our work greatly expands the current knowledge of scorpion venoms. We found ten known types and nine novel venom peptides and proteins. These molecules provide a rich, hitherto-unexplored resource for drug development as well as clues into the evolution of the scorpion venom arsenal".
To humans, the sting of scorpions from the Euscorpiidae family tend to be quite mild – about as painful as a mosquito bite. S. jendeki venom has never been studied before. The researchers found that it contains ten known poisons, with markedly diverse modes of action and nine new types of venom peptide, whose biological effects are yet to be determined. The scorpion itself, however, is considered harmless – probably because it cannot deliver enough of the poison to cause any damage to a healthy human. Interestingly, neurotoxins, which are major poisons in the venom of another scorpion species that can kill humans, were not found in the S. jendeki venom.
Ma concludes, "Many types of venom peptides and proteins have been obtained from diverse scorpion species. Some are widely distributed among scorpions from different families, while others, like some of those discovered in our study, appear to be restricted to particular scorpion lineages. The presence of these common and uncommon venom molecules among different lineages reflects the dynamic evolutionary process of the scorpion venom arsenal".1. Transcriptome analysis of the venom gland of the scorpion Scorpiops jendeki: implication for the evolution of the scorpion venom arsenal
BMC Genomics (in press)
2. BMC Genomics is an open access journal publishing original peer-reviewed research articles in all aspects of genome-scale analysis, functional genomics, and proteomics. BMC Genomics (ISSN 1471-2164) is indexed/tracked/covered by PubMed, MEDLINE, BIOSIS, CAS, Scopus, EMBASE, Zoological Record, Thomson Reuters (ISI) and Google Scholar.
3. BioMed Central (www.biomedcentral.com) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
Graeme Baldwin | EurekAlert!
Not of Divided Mind
19.01.2017 | Hertie-Institut für klinische Hirnforschung (HIH)
CRISPR meets single-cell sequencing in new screening method
19.01.2017 | CeMM Forschungszentrum für Molekulare Medizin der Österreichischen Akademie der Wissenschaften
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
19.01.2017 | Earth Sciences
19.01.2017 | Life Sciences
19.01.2017 | Physics and Astronomy